NCT04692155 2023-09-28CHOP U2University of Alabama at BirminghamPhase 1/2 Terminated1 enrolled 5 charts
NCT05152459 2023-05-31Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular LymphomaCity of Hope Medical CenterPhase 1/2 Withdrawn